Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study.
Zou F, Faleck D, Thomas A, Harris J, Satish D, Wang X, Charabaty A, Ernstoff MS, Glitza Oliva IC, Hanauer S, McQuade J, Obeid M, Shah A, Richards DM, Sharon E, Wolchok J, Thompson J, Wang Y.
Zou F, et al. Among authors: charabaty a.
J Immunother Cancer. 2021 Nov;9(11):e003277. doi: 10.1136/jitc-2021-003277.
J Immunother Cancer. 2021.
PMID: 34789551
Free PMC article.